Pulmonary Metastasis

3

Review clinical trials related to Pulmonary Metastasis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Pediatric subjects aged 6-17 with biopsy confirmed cancer and imaging findings suspicious for pulmonary metastatic disease scheduled to undergo pulmonary metastasectomy via and open or minimally invasive approach.

Participants needed: 10
Trial details
Phase: Phase 1Age: 6-17Biological sex: AllType: InterventionalSponsor: Ann & Robert H Lurie Children's Hospital of ChicagoUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Patients 6-17 years of age at the time of study enrollment [+8]

Any medical condition that in the opinion of the investigators could potentially... [+9]

Status: Not yet recruiting

HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections

The purpose of this study is the identification of the intersegmental plane and navigation during sublobar pulmonary resections in lung cancer using Hyperspectral Imaging, the comparison with ICG fluorescence intersegmental plane identification, and the establishment of automatic intersegmental plane navigation using machine learning strategies for intraoperative navigation.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: LungenClinic GrosshansdorfUpdated: Jan 9, 2023Locations: 1
Eligibility criteria

Histologically confirmed lung cancer stage I/II or malignancy suspicious nodules [+8]

Requirement of a lobectomy or pneumonectomy to achieve complete resection [+9]

Status: Not yet recruiting

A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis

Although patients with locally advanced rectal cancer and resectable liver/pulmonary metastasis could benefit from surgery resection, these patients still have a poorer prognosis compared to those without distal metastasis. Based on previous studies, there is no confirmation of whether these patients could benefit from preoperative immunotherapy combined with conventional chemoradiotherapy. This study proposes a combination therapy, preoperative short-course radiotherapy followed by neoadjuvant chemotherapy and anti-PD-1 immunotherapy, for microsatellite-stable patients with locally advanced rectal cancer and resectable liver/pulmonary metastasis, to assess its impact on tumor retreat, decline of postoperative metastasis and recurrence, and the disease-free survival and overall survival of patients. Besides, this study will provide high-level medical evidence for future clinical treatment of patients with advanced rectal cancer.

Participants needed: 52
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Nov 14, 2022Locations: 1
Eligibility criteria

Age 18~75; [+25]

Age <18 or >75 years; [+25]